Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetes

被引：7
|
作者：
Lee, J. -Y. [1 ,2 ]
Cho, Y. [1 ,2 ]
Lee, M. [1 ,2 ]
Lee, Y. -H. [1 ,2 ,3 ]
Lee, B. -W. [1 ,2 ,3 ]
Kang, E. S. [1 ,2 ,3 ]
Cha, B. -S. [1 ,2 ,3 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Grad Sch, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Inst Endocrine Res, Coll Med, Seoul, South Korea
来源：
DIABETES & METABOLISM | 2018年 / 44卷 / 05期
关键词：
INSULIN-RESISTANCE; DOUBLE-BLIND; PIOGLITAZONE; TOLERABILITY; METFORMIN; THERAPY; VILDAGLIPTIN; MONOTHERAPY; 24-WEEK;
D O I：
10.1016/j.diabet.2017.11.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：452 / 455
页数：4
相关论文
共 50 条
  • [1] Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
    Bae, Jaehyun
    Park, Taegyun
    Kim, Hyeyoung
    Lee, Minyoung
    Cha, Bong-Soo
    DIABETES & METABOLISM JOURNAL, 2021, 45 (03) : 326 - 336
  • [2] Efficacy and safety of novel thiazolidinedione lobeglitazone for managing type-2 diabetes a meta-analysis
    Dutta, Deep
    Bhattacharya, Saptarshi
    Kumar, Manoj
    Datta, Priyankar K.
    Mohindra, Ritin
    Sharma, Meha
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (01)
  • [3] Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
    Lim, Soo
    Kim, Kyoung Min
    Kim, Sin Gon
    Kim, Doo Man
    Woo, Jeong-Taek
    Chung, Choon Hee
    Ko, Kyung Soo
    Park, Jeong Hyun
    Park, Yongsoo
    Kim, Sang Jin
    Jang, Hak Chul
    Choi, Dong Seop
    DIABETES & METABOLISM JOURNAL, 2017, 41 (05) : 377 - 385
  • [4] Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
    Lee, Yong-ho
    Kim, Jae Hyeon
    Kim, So Ra
    Jin, Heung Yong
    Rhee, Eun-Jung
    Cho, Young Min
    Lee, Byung-Wan
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (01) : 60 - 69
  • [5] Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
    Kim, Kyung-Soo
    Hong, Sangmo
    Ahn, Hong-Yup
    Park, Cheol-Young
    DIABETES THERAPY, 2021, 12 (01) : 171 - 181
  • [6] Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
    Kyung-Soo Kim
    Sangmo Hong
    Hong-Yup Ahn
    Cheol-Young Park
    Diabetes Therapy, 2021, 12 : 171 - 181
  • [7] Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis
    Joshi, Shashank R.
    Das, Saibal
    Xaviar, Suja
    Samajdar, Shambo Samrat
    Saha, Indranil
    Sarkar, Sougata
    Mukherjee, Shatavisa
    Tripathi, Santanu Kumar
    Pal, Jyotirmoy
    Chatterjee, Nandini
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (01)
  • [8] Chiglitazar and Thiazolidinedione in patients with type 2 diabetes: Which is better?
    Reddy, Kotha Sugunakar
    Gaur, Archana
    Varatharajan, Sakthivadivel
    Morya, Arvind Kumar
    WORLD JOURNAL OF DIABETES, 2024, 15 (03)
  • [9] CHANGES IN BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOBEGLITAZONE, A NOVEL THIAZOLIDINEDIONE, OVER 52 WEEKS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL
    Kim, K. M.
    Lim, S.
    Jang, H. C.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S382 - S382
  • [10] Safety and efficacy of saxagliptin added to thiazolidinedione over 76 weeks in patients with type 2 diabetes mellitus
    Hollander, Priscilla L.
    Li, Jia
    Frederich, Robert
    Allen, Elsie
    Chen, Roland
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (02): : 125 - 135
12345